Joanna Poulton, University of Oxford, Oxford, UK
Laurence Bindoff, Haukeland Hospital, Haukeland Hospital, Bergen, Norway
Published online: April 2001
DOI: 10.1038/npg.els.0002287
Mitochondrial diseases are rare multisystem diseases primarily affecting muscle, brain, heart and liver. The unique biology of the mitochondrion causes variability in phenotypic severity and transmission.
Keywords: mitochondrial DNA; MELAS; MERRF; NARP; LHON
|
Figure 1.
The mitochondrial respiratory chain (MRC). Reduced cofactors such as NADH and flavoproteins (as found in succinate dehydrogenase) are reoxidized by the MRC. In the process, electrons are donated into the MRC and subsequently pass from complex to complex down an energy gradient. Sufficient energy is generated at three steps (complexes I, III and IV) to drive the extrusion of protons (H+) that cannot re‐enter the inner membrane. This creates an electrochemical gradient, which is discharged back into the mitochondrion via complex V; the energy this generates is used to drive phosphorylation of ADP to ATP. Thus, substrate oxidation is linked to phosphorylation of ADP; hence, oxidative phosphorylation. The final electron acceptor is molecular oxygen. |
|
Figure 2.
The normal mitochondrial genome. Coding information is contained on both strands, in nonoverlapping units. The strands can be separated by density centrifugation into heavy (H strand) and light (L strand). An approximately 1‐kb region, called the D‐loop, contains the control elements, including transcription start sites for both H and L strands and replication start site for the H strand. Only 13 proteins of the 70 or more proteins in the mitochondrial respiratory chain are encoded by |
References
Anderson S, Bankier AT, Barrell BG et al. (1981) Sequence and organisation of the human mitochondrial genome. Nature 290: 457–465.
Bindoff LA (1999) Treatment of mitochondrial disorders: practical and theoretical issues. European Journal of Paediatric Neurology 3: 201–208.
Jenuth J, Peterson A, Fu K and Shoubridge E (1996) Random genetic drift in the female germline explains the rapid segregation of mammalian mitochondrial DNA. Nature Genetics 14: 146–151.
Lightowlers R, Chinnery P, Turnbull D and Howell N (1997) Mammalian mitochondrial genetics: hereditary, heteroplasmy and disease. Trends in Genetics 13: 450–455.
Luft R (1994) The development of mitochondrial medicine. Proceedings of the National Academy of Sciences of the USA 91: 8731–8738.
Neupert W (1997) Protein import into mitochondria. Annual Review of Biochemistry 66: 863–917.
Poulton J (1998) Gene table: Mitochondrial gene mutations. European Journal of Paediatric Neurology 2: 99–103.
Poulton J and Turnbull D (2000) Report of the 74th ENMC International Workshop: Mitochondrial Diseases, November 1999, Naarden, The Netherlands. Neuromuscular Disorders (in press).
Poulton J, Deadman ME, Bindoff L et al. (1993) Families of mtDNA re‐arrangements can be detected in patients with mtDNA deletions: duplications may be a transient intermediate form. Human Molecular Genetics 2: 23–30.
Simon DK and Johns DR (1999) Mitochondrial disorders: clinical and genetic features. Annual Review of Medicine 50: 111–127.
Zeviani M, Tiranti V and Piantadosi C (1998) Mitochondrial disorders. Medicine (Baltimore) 77: 59–72.
Further Reading
Attardi G and Schatz G (1988) Biogenesis of mitochondria. Annual Review of Cell Biology 4: 289–333.
Bindoff LA, Brown G and Poulton J (1997) Mitochondrial myopathies. In: Emery AEH (ed.) Diagnostic Criteria for Neuromuscular Disorders, pp. 85–90. London: RSM Press
Darley‐Usmar V and Schapira AHV (1994) Mitochondria: DNA, Proteins and Disease. London: Portland Press.
Enriquez JA and Attardi G (1996) Evidence for aminoacylation‐induced conformational changes in human mitochondrial tRNAs. Proceedings of the National Academy of Sciences of the USA 93: 8300–8305.
Howell N (1999) Human mitochondrial diseases: answering questions and questioning answers. International Review of Cytology 186: 49–116.
Howell N, Bindoff LA, McCullough DA et al. (1991) Leber hereditary optic neuropathy: identification of the same mitochondrial ND1 mutation in six pedigrees. American Journal of Human Genetics 49: 939–950.
King MP and Attardi G (1989) Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation. Science 246(4929): 500–503.
Shoffner JM, Lott MT, Lezza AM et al. (1990) Myoclonic epilepsy and ragged‐red fiber disease (MERRF) is associated with a mitochondrial DNA tRNA(Lys) mutation. Cell 61: 931–937.
Smeitink J and van den Heuvel L (1999) Human mitochondrial complex I in health and disease. American Journal of Human Genetics 64: 1505–1510.
Tiranti V, Jaksch M, Hofmann S et al. (1999) Loss‐of‐function mutations of SURF‐1 are specifically associated with Leigh syndrome with cytochrome c oxidase deficiency. Annals of Neurology 46: 161–166.
Wallace DC, Singh G, Lott MT et al. (1988) Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science 242(4884): 1427–1430.
Weber K, Wilson J, Taylor L et al. (1997) A new mtDNA mutation showing restriction to skeletal muscle and accumulation with time. American Journal of Human Genetics 60: 373–380.
Zeviani M, Servidei S, Gellera C et al. (1989) An autosomal dominant disorder with multiple deletions of mitochondrial DNA starting at the D‐loop region. Nature 339(6222): 309–311.
* Required Field
Copyright © by John Wiley & Sons, Inc., or related companies. All rights reserved.
